About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Liraglutide Use in Prader-Willi Syndrome | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 4NCT01542242

Liraglutide Use in Prader-Willi Syndrome

Liraglutide is a glucagon like peptide -1 (GLP-1) agonist, which is approved for use in patients with type 2 diabetes. Studies of liraglutide have shown an appetite suppressive effect and has been ass...

Lead sponsor: Vancouver General Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Vancouver General Hospital

Collaborators

Novo Nordisk A/S

Age

19 - No limit years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Prader Willi Syndrome, Diabetes Type 2

Exclusion Criteria

•Previous or family history of Medullary Carcinoma of the Thyroid or multiple endocrine neoplasia syndrome.
•Subjects with acute or chronic Pancreatitis

Related studies

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259 · Diabetes Mellitus Type 2, Childhood-Onset

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery

NCT05934409 · Diabetes Mellitus Type 2

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.

NCT03821636 · Diabetes Mellitus Type 2 in Obese

Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial

NCT06957093 · Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2015Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment1

Start dateFeb 2012

Last updatedDec 9, 2015

Condition

Diabetes Mellitus Type 2 Prader Willi Syndrome

Locations shown

Vancouver General Hospital - Diamond Center

Vancouver, British Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2015Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions